The heavy selling pressure might have exhausted for Molina (MOH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Molina Healthcare draws investor interest with strong earnings growth, contract wins and premium revenue momentum despite rising costs.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina (MOH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
The DCF model implemented in this article suggests that Molina Healthcare is undervalued by 34.66%. Between 2020 and 2024, a period in which the total enrollment in Medicaid experienced a slight decline, the revenues of Molina Healthcare increased by 109.29%. The U.S. Government expects to cut the Medicaid budget by $880 billion in the following ten years.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Healthcare, Inc. (NYSE:MOH ) Q1 2025 Earnings Conference Call April 24, 2025 8:00 AM ET Company Participants Jeffrey Geyer - Head of Investor Relations Joe Zubretsky - President and CEO Mark Keim - CFO Conference Call Participants Stephen Baxter - Wells Fargo Andrew Mok - Barclays Josh Raskin - Nephron Research A.J. Rice - UBS Justin Lake - Wolfe Research John Stansel - JP Morgan Sarah James - Cantor Fitzgerald Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Lance Wilkes - Bernstein Michael Ha - Baird George Hill - Deutsche Bank Dave Windley - Jefferies Operator Good day and welcome to the Molina Healthcare First Quarter 2025 Earnings Conference Call.
MOH continues to expect 2025 premium revenues to be around $42 billion.
Although the revenue and EPS for Molina (MOH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Molina (MOH) came out with quarterly earnings of $6.08 per share, beating the Zacks Consensus Estimate of $5.86 per share. This compares to earnings of $5.73 per share a year ago.
MOH's first-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
Evaluate the expected performance of Molina (MOH) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.